Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 25c

Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.25), $0.25 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.

You May Also Be Interested In

• Yen Jumps More Than 1% To Trade At 158.22 Per Us Dollar
• Braze Inc (BRZE) PT Raised to $40 at DA Davidson
• DA Davidson Reiterates Buy Rating on Jack Henry (JKHY) Following Cybersecurity Incident